{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,11]],"date-time":"2024-07-11T13:21:57Z","timestamp":1720704117654},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Epidemiology"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1016\/j.canep.2016.08.020","type":"journal-article","created":{"date-parts":[[2016,9,8]],"date-time":"2016-09-08T19:41:03Z","timestamp":1473363663000},"page":"161-166","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Exploratory analysis of  ERCC2  DNA methylation in survival among pediatric medulloblastoma patients"],"prefix":"10.1016","volume":"44","author":[{"given":"Emilyn","family":"Banfield","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Austin L.","family":"Brown","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erin C.","family":"Peckham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Surya P.","family":"Rednam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey","family":"Murray","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. Fatih","family":"Okcu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura E.","family":"Mitchell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Murali M.","family":"Chintagumpala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ching C.","family":"Lau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael E.","family":"Scheurer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philip J.","family":"Lupo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.canep.2016.08.020_bib0005","doi-asserted-by":"crossref","first-page":"83","DOI":"10.3322\/caac.21219","article-title":"Childhood and adolescent cancer statistics, 2014","volume":"64","author":"Ward","year":"2014","journal-title":"CA Cancer J. Clin."},{"issue":"10","key":"10.1016\/j.canep.2016.08.020_bib0010","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/S1470-2045(06)70867-1","article-title":"Risk-adapted craniospinal radiotherapy followed by high-dose chemotherapy and stem-cell rescue in children with newly diagnosed medulloblastoma (St. Jude Medulloblastoma-96): long-term results from a prospective, multicentre trial","volume":"7","author":"Gajjar","year":"2006","journal-title":"Lancet Oncol."},{"issue":"11","key":"10.1016\/j.canep.2016.08.020_bib0015","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1200\/JCO.2010.30.2810","article-title":"Definition of disease-risk stratification groups in childhood medulloblastoma using combined clinical, pathologic, and molecular variables","volume":"29","author":"Ellison","year":"2011","journal-title":"J. Clin. Oncol."},{"issue":"4","key":"10.1016\/j.canep.2016.08.020_bib0020","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1007\/s00401-012-0958-8","article-title":"Molecular subgroups of medulloblastoma: an international meta-analysis of transcriptome, genetic aberrations, and clinical data of WNT, SHH, group 3, and group 4 medulloblastomas","volume":"123","author":"Kool","year":"2012","journal-title":"Acta Neuropathol."},{"issue":"6","key":"10.1016\/j.canep.2016.08.020_bib0025","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1038\/nrneurol.2012.78","article-title":"The clinical implications of medulloblastoma subgroups","volume":"8","author":"Northcott","year":"2012","journal-title":"Nat. Rev. Neurol."},{"issue":"12","key":"10.1016\/j.canep.2016.08.020_bib0030","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1089\/ars.2010.3369","article-title":"Interrogation of nucleotide excision repair capacity: impact on platinum-based cancer therapy","volume":"14","author":"Earley","year":"2011","journal-title":"Antioxid. Redox Signal."},{"issue":"5","key":"10.1016\/j.canep.2016.08.020_bib0035","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S0305-7372(98)90056-1","article-title":"Platinum-DNA adduct, nucleotide excision repair and platinum based anti-cancer chemotherapy","volume":"24","author":"Reed","year":"1998","journal-title":"Cancer Treat. Rev."},{"issue":"2","key":"10.1016\/j.canep.2016.08.020_bib0040","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.canep.2014.12.009","article-title":"Genetic variability of DNA repair mechanisms and glutathione-S-transferase genes influences treatment outcome in osteosarcoma","volume":"39","author":"Goricar","year":"2015","journal-title":"Cancer Epidemiol."},{"issue":"4","key":"10.1016\/j.canep.2016.08.020_bib0045","doi-asserted-by":"crossref","first-page":"12967","DOI":"10.4238\/2015.October.21.17","article-title":"Influence of ERCC2 gene polymorphisms on the treatment outcome of osteosarcoma","volume":"14","author":"Liu","year":"2015","journal-title":"Genet. Mol. Res. GMR"},{"issue":"3","key":"10.1016\/j.canep.2016.08.020_bib0050","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/j.lungcan.2012.04.016","article-title":"Clinical significance of ERCC2 haplotype-tagging single nucleotide polymorphisms in patients with unresectable non-small cell lung cancer treated with first-line platinum-based chemotherapy","volume":"77","author":"Kim","year":"2012","journal-title":"Lung Cancer (Amst., Neth.)"},{"issue":"2","key":"10.1016\/j.canep.2016.08.020_bib0055","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.lungcan.2013.07.024","article-title":"Polymorphisms in DNA repair and apoptosis-related genes and clinical outcomes of patients with non-small cell lung cancer treated with first-line paclitaxel-cisplatin chemotherapy","volume":"82","author":"Lee","year":"2013","journal-title":"Lung Cancer (Amst., Neth.)"},{"issue":"2","key":"10.1016\/j.canep.2016.08.020_bib0060","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.canlet.2014.07.023","article-title":"Pharmacogenetics of the DNA repair pathways in advanced non-small cell lung cancer patients treated with platinum-based chemotherapy","volume":"353","author":"Sullivan","year":"2014","journal-title":"Cancer Lett."},{"issue":"1","key":"10.1016\/j.canep.2016.08.020_bib0065","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/tpj.2011.38","article-title":"Genome-wide meta-analysis identifies variants associated with platinating agent susceptibility across populations","volume":"13","author":"Wheeler","year":"2013","journal-title":"Pharmacogenom. J."},{"issue":"19","key":"10.1016\/j.canep.2016.08.020_bib0070","first-page":"5457","article-title":"Regulation of cisplatin resistance and homologous recombinational repair by the TFIIH subunit XPD","volume":"62","author":"Aloyz","year":"2002","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.canep.2016.08.020_bib0075","first-page":"225","article-title":"Expression analysis of genes involved in oxaliplatin response and development of oxaliplatin-resistant HT29 colon cancer cells","volume":"29","author":"Plasencia","year":"2006","journal-title":"Int. J. Oncol."},{"issue":"1","key":"10.1016\/j.canep.2016.08.020_bib0080","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/1476-4598-4-18","article-title":"ABCC5, ERCC2, XPA and XRCC1 transcript abundance levels correlate with cisplatin chemoresistance in non-small cell lung cancer cell lines","volume":"4","author":"Weaver","year":"2005","journal-title":"Mol. Cancer"},{"issue":"10","key":"10.1016\/j.canep.2016.08.020_bib0085","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1158\/2159-8290.CD-14-0623","article-title":"Somatic ERCC2 mutations correlate with cisplatin sensitivity in muscle-invasive urothelial carcinoma","volume":"4","author":"Van Allen","year":"2014","journal-title":"Cancer Discov."},{"key":"10.1016\/j.canep.2016.08.020_bib0090","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1186\/s13014-015-0558-6","article-title":"ERCC2 polymorphisms and radiation-induced adverse effects on normal tissue: systematic review with meta-analysis and trial sequential analysis","volume":"10","author":"Song","year":"2015","journal-title":"Radiat. Oncol. (Lond., Engl.)"},{"issue":"11","key":"10.1016\/j.canep.2016.08.020_bib0095","doi-asserted-by":"crossref","first-page":"3889","DOI":"10.1158\/1078-0432.CCR-08-2715","article-title":"Association of XPD polymorphisms with severe toxicity in non-small cell lung cancer patients in a Chinese population","volume":"15","author":"Wu","year":"2009","journal-title":"Clin. Cancer Res."},{"issue":"54","key":"10.1016\/j.canep.2016.08.020_bib0100","doi-asserted-by":"crossref","first-page":"8061","DOI":"10.1038\/sj.onc.1208955","article-title":"Epigenetic changes to the MDR1 locus in response to chemotherapeutic drugs","volume":"24","author":"Baker","year":"2005","journal-title":"Oncogene"},{"issue":"10","key":"10.1016\/j.canep.2016.08.020_bib0105","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/nrg3270","article-title":"DNA methylation profiling in the clinic: applications and challenges","volume":"13","author":"Heyn","year":"2012","journal-title":"Nat. Rev. Genet."},{"issue":"2","key":"10.1016\/j.canep.2016.08.020_bib0110","doi-asserted-by":"crossref","first-page":"331","DOI":"10.2217\/epi.09.31","article-title":"Methods in DNA methylation profiling","volume":"1","author":"Zuo","year":"2009","journal-title":"Epigenomics"},{"issue":"6","key":"10.1016\/j.canep.2016.08.020_bib0115","doi-asserted-by":"crossref","first-page":"R43","DOI":"10.1186\/gb-2012-13-6-r43","article-title":"Functional annotation of the human brain methylome identifies tissue-specific epigenetic variation across brain and blood","volume":"13","author":"Davies","year":"2012","journal-title":"Genome Biol."},{"key":"10.1016\/j.canep.2016.08.020_bib0120","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1186\/1471-2164-15-145","article-title":"Methylation quantitative trait loci (meQTLs) are consistently detected across ancestry, developmental stage, and tissue type","volume":"15","author":"Smith","year":"2014","journal-title":"BMC Genom."},{"issue":"25","key":"10.1016\/j.canep.2016.08.020_bib0125","doi-asserted-by":"crossref","first-page":"4202","DOI":"10.1200\/JCO.2006.06.4980","article-title":"Phase III study of craniospinal radiation therapy followed by adjuvant chemotherapy for newly diagnosed average-risk medulloblastoma","volume":"24","author":"Packer","year":"2006","journal-title":"J. Clin. Oncol."},{"issue":"3","key":"10.1016\/j.canep.2016.08.020_bib0130","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1093\/bioinformatics\/btt684","article-title":"ChAMP: 450k chip analysis methylation pipeline","volume":"30","author":"Morris","year":"2014","journal-title":"Bioinform. (Oxf., Engl.)"},{"key":"10.1016\/j.canep.2016.08.020_bib0135","unstructured":"S. Davis, P. Du, S. Bilke, et al. Methylumi: handle Illumina methylation data. R package version 2.16.0, 2015."},{"issue":"2","key":"10.1016\/j.canep.2016.08.020_bib0140","doi-asserted-by":"crossref","first-page":"203","DOI":"10.4161\/epi.23470","article-title":"Discovery of cross-reactive probes and polymorphic CpGs in the Illumina Infinium HumanMethylation450 microarray","volume":"8","author":"Chen","year":"2013","journal-title":"Epigenetics"},{"issue":"7","key":"10.1016\/j.canep.2016.08.020_bib0145","doi-asserted-by":"crossref","first-page":"e90","DOI":"10.1093\/nar\/gkt090","article-title":"Low-level processing of illumina infinium DNA methylation beadarrays","volume":"41","author":"Triche","year":"2013","journal-title":"Nucl. Acids Res."},{"issue":"2","key":"10.1016\/j.canep.2016.08.020_bib0150","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1093\/bioinformatics\/bts680","article-title":"A beta-mixture quantile normalization method for correcting probe design bias in Illumina Infinium 450k DNA methylation data","volume":"29","author":"Teschendorff","year":"2013","journal-title":"Bioinform.(Oxf., Engl.)"},{"issue":"11","key":"10.1016\/j.canep.2016.08.020_bib0155","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1093\/bioinformatics\/btr171","article-title":"Independent surrogate variable analysis to deconvolve confounding factors in large-scale microarray profiling studies","volume":"27","author":"Teschendorff","year":"2011","journal-title":"Bioinform. (Oxf., Engl.)"},{"issue":"1","key":"10.1016\/j.canep.2016.08.020_bib0160","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1093\/biostatistics\/kxj037","article-title":"Adjusting batch effects in microarray expression data using empirical Bayes methods","volume":"8","author":"Johnson","year":"2007","journal-title":"Biostat. (Oxf., Engl.)"},{"key":"10.1016\/j.canep.2016.08.020_bib0165","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/1471-2105-13-86","article-title":"DNA methylation arrays as surrogate measures of cell mixture distribution","volume":"13","author":"Houseman","year":"2012","journal-title":"BMC Bioinform."},{"issue":"6","key":"10.1016\/j.canep.2016.08.020_bib0170","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1007\/s00439-011-0993-x","article-title":"Statistical approaches for the analysis of DNA methylation microarray data","volume":"129","author":"Siegmund","year":"2011","journal-title":"Hum. Genet."},{"issue":"8","key":"10.1016\/j.canep.2016.08.020_bib0175","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1016\/j.jclinepi.2014.03.012","article-title":"False discovery rate control is a recommended alternative to Bonferroni-type adjustments in health studies","volume":"67","author":"Glickman","year":"2014","journal-title":"J. Clin. Epidemiol."},{"issue":"4","key":"10.1016\/j.canep.2016.08.020_bib0180","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1002\/pbc.24366","article-title":"Glutathione S-transferase P1 single nucleotide polymorphism predicts permanent ototoxicity in children with medulloblastoma","volume":"60","author":"Rednam","year":"2013","journal-title":"Pediatr. Blood Cancer"},{"issue":"5","key":"10.1016\/j.canep.2016.08.020_bib0185","doi-asserted-by":"crossref","first-page":"e96301","DOI":"10.1371\/journal.pone.0096301","article-title":"The effect of XPD polymorphisms on digestive tract cancers risk: a meta-analysis","volume":"9","author":"Du","year":"2014","journal-title":"PloS One"},{"issue":"3","key":"10.1016\/j.canep.2016.08.020_bib0190","doi-asserted-by":"crossref","first-page":"251","DOI":"10.2169\/internalmedicine.54.3256","article-title":"XPD Lys751Gln polymorphisms and the risk of esophageal cancer: an updated meta-analysis","volume":"54","author":"Guo","year":"2015","journal-title":"Intern. Med. (Tokyo, Jpn.)"},{"issue":"2","key":"10.1016\/j.canep.2016.08.020_bib0195","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.gene.2013.08.053","article-title":"Genetic polymorphisms of xeroderma pigmentosum group D gene Asp312Asn and Lys751Gln and susceptibility to prostate cancer: a systematic review and meta-analysis","volume":"530","author":"Ma","year":"2013","journal-title":"Gene"},{"issue":"9","key":"10.1016\/j.canep.2016.08.020_bib0200","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1093\/carcin\/bgl017","article-title":"The XPD 751Gln allele is associated with an increased risk for esophageal adenocarcinoma: a population-based case-control study in Sweden","volume":"27","author":"Ye","year":"2006","journal-title":"Carcinogenesis"},{"issue":"1","key":"10.1016\/j.canep.2016.08.020_bib0205","doi-asserted-by":"crossref","first-page":"231","DOI":"10.7314\/APJCP.2013.14.1.231","article-title":"XPD Lys751Gln and Asp312Asn polymorphisms and gastric cancer susceptibility: a meta-analysis of case-control studies","volume":"14","author":"Yin","year":"2013","journal-title":"Asian Pac. J. Cancer Prev."},{"issue":"13","key":"10.1016\/j.canep.2016.08.020_bib0210","doi-asserted-by":"crossref","first-page":"2479","DOI":"10.1016\/j.ejca.2010.05.008","article-title":"ERCC2 Lys751Gln polymorphism is associated with lung cancer among Caucasians","volume":"46","author":"Zhang","year":"2010","journal-title":"Eur. J. Cancer (Oxf., Engl., 1990)"},{"issue":"2","key":"10.1016\/j.canep.2016.08.020_bib0215","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1007\/s10549-010-0863-6","article-title":"Meta-analysis of two ERCC2 (XPD) polymorphisms, Asp312Asn and Lys751Gln, in breast cancer","volume":"124","author":"Pabalan","year":"2010","journal-title":"Breast Cancer Res. Treat."},{"issue":"2","key":"10.1016\/j.canep.2016.08.020_bib0220","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.canlet.2014.01.005","article-title":"Nucleotide excision repair: why is it not used to predict response to platinum-based chemotherapy?","volume":"346","author":"Bowden","year":"2014","journal-title":"Cancer Lett."},{"issue":"4","key":"10.1016\/j.canep.2016.08.020_bib0225","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.dnarep.2012.01.003","article-title":"DNA repair gene expression level in peripheral blood and tumour tissue from non-small cell lung cancer and head and neck squamous cell cancer patients","volume":"11","author":"Schena","year":"2012","journal-title":"DNA Repair"}],"container-title":["Cancer Epidemiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1877782116301436?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1877782116301436?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,7,17]],"date-time":"2018-07-17T21:24:37Z","timestamp":1531862677000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1877782116301436"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10]]},"references-count":45,"alternative-id":["S1877782116301436"],"URL":"https:\/\/doi.org\/10.1016\/j.canep.2016.08.020","relation":{},"ISSN":["1877-7821"],"issn-type":[{"value":"1877-7821","type":"print"}],"subject":[],"published":{"date-parts":[[2016,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Exploratory analysis of ERCC2 DNA methylation in survival among pediatric medulloblastoma patients","name":"articletitle","label":"Article Title"},{"value":"Cancer Epidemiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canep.2016.08.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}